跳至主要内容
临床试验/NL-OMON39170
NL-OMON39170已完成不适用

Treatment of Endometriosis with Epigallocatechin gallate: a double-blind randomized placebo-controlled crossover pilot trial. - TEE- study

Vrije Universiteit Medisch Centrum0 个研究点目标入组 7 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
7

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Signed and dated informed consent
  • * Pain associated with visually proven endometriosis determined by diagnostic laparoscopy start of treatment (but not in 6 weeks prior to screening)
  • * The use of oral contraceptives.
  • * Persistent endometriosis related pain; Threshold for pelvic painscore: minimum of 40 mm on VAS
  • * Transvaginal ultrasound within the last 3 months.
  • * Good general health (except for endometriosis).

排除标准

  • * Previous/current use of hormonal agents including:
  • GnRH agonists (not within 6 cycles), progestins (not within 3 cycles), IUD (mirena), specific oral contraceptives (Diane 35 and three phase oral contraceptives, not within one cycle).
  • * Breastfeeding
  • * Blood coagulation disorders
  • * Pregnancy
  • * Liver dysfunction
  • * Usage of any prescription drug

研究者

相似试验